Related Experiment Video
Updated: Jul 11, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Glucagonoma syndrome: survival 21 years with concurrent liver metastases
Spyros P Dourakis1, Alexandra Alexopoulou, Kleoniki K Georgousi
1Second Department of Medicine, University of Athens Medical School, Hippokration General Hospital, Athens, Greece.
Abstract:
A patient who survived for 21 years since initial discovery of glucagonoma with concurrent liver metastases is described. Psychiatric symptoms, weight loss, necrolytic migratory erythema, diarrhea, and diabetes mellitus developed gradually after diagnosis of the tumor. No specific treatment was administered. The longevity of this patient may be related to the slow tumor growth expressed histologically by ischemic necrosis of the malignant cells and in imaging by extensive tumor calcifications, a very rare finding in this type of the tumor.
